{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:50:52Z","timestamp":1769075452141,"version":"3.49.0"},"reference-count":45,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/tmtw8336","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T07:28:01Z","timestamp":1764314881000},"page":"4658-4675","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a prediction model for lymph node metastasis in oral squamous cell carcinoma using serum biomarkers"],"prefix":"10.62347","volume":"15","author":[{"given":"Li","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1502283","DOI":"10.3389\/fonc.2024.1502283","article-title":"Exosomes in oral squamous cell carcinoma: functions, challenges, and potential applications","volume":"14","author":"Zhao","year":"2025","unstructured":"Zhao B, Li Z and Li R. Exosomes in oral squamous cell carcinoma: functions, challenges, and potential applications. Front Oncol 2025; 14: 1502283.","journal-title":"Front Oncol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s00432-022-04028-8","article-title":"Current trends of targeted therapy for oral squamous cell carcinoma","volume":"148","author":"Li","year":"2022","unstructured":"Li H, Zhang Y, Xu M and Yang D. Current trends of targeted therapy for oral squamous cell carcinoma. J Cancer Res Clin Oncol 2022; 148: 2169-2186.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Miura KI, Otsuru M, Fukushima H, Omori K, Naruse T, Umeda M and Yamada T. Clinical study on postoperative treatment for patients at high risk of oral squamous cell carcinoma recurrence. Cureus 2025; 17: e78395.","DOI":"10.7759\/cureus.78395"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"107165","DOI":"10.1016\/j.oraloncology.2024.107165","article-title":"Diagnosis of lymph node metastasis in oral squamous cell carcinoma by an MRI-based deep learning model","volume":"161","author":"Yang","year":"2025","unstructured":"Yang L, Zhang S, Li J, Feng C, Zhu L, Li J, Lin L, Lv X, Su K, Lao X, Chen J, Cao W, Li S, Tang H, Chen X, Liang L, Shang W, Cao Z, Qiu F, Li J, Luo W, Gao S, Wang S, Zeng B, Duan W, Ji T, Liao G and Liang Y. Diagnosis of lymph node metastasis in oral squamous cell carcinoma by an MRI-based deep learning model. Oral Oncol 2025; 161: 107165.","journal-title":"Oral Oncol"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Altuwaijri AA, Aldrees TM and Alessa MA. Prevalence of metastasis and involvement of level IV and V in oral squamous cell carcinoma: a systematic review. Cureus 2021; 13: e20255.","DOI":"10.7759\/cureus.20255"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.2217\/fon-2021-1379","article-title":"The diagnostic value of soluble TIM-3 in oral squamous cell carcinoma","volume":"10","author":"Lu","year":"2022","unstructured":"Lu K, Ma H, Wang T, Huang Y and Ru M. The diagnostic value of soluble TIM-3 in oral squamous cell carcinoma. Future Oncol 2022; 10: 2217.","journal-title":"Future Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1597086","DOI":"10.3389\/fonc.2025.1597086","article-title":"Recent advances in biomarker detection of oral squamous cell carcinoma","volume":"15","author":"Liu","year":"2025","unstructured":"Liu L, Zhong X, Zhong Y and Li L. Recent advances in biomarker detection of oral squamous cell carcinoma. Front Oncol 2025; 15: 1597086.","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"115445","DOI":"10.1016\/j.bcp.2023.115445","article-title":"Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases","volume":"209","author":"Bailly","year":"2023","unstructured":"Bailly C, Thuru X, Goossens L and Goossens JF. Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases. Biochem Pharmacol 2023; 209: 115445.","journal-title":"Biochem Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/ijms22010379","article-title":"LAG-3, TIM-3 and VISTA expression on tumor-infiltrating lymphocytes in oropharyngeal squamous cell carcinoma-potential biomarkers for targeted therapy concepts","volume":"22","author":"Wuerdemann","year":"2020","unstructured":"Wuerdemann N, Pütz K, Eckel H, Jain R, Wittekindt C, Huebbers CU, Sharma SJ, Langer C, Gattenlöhner S, Büttner R, Speel EJ, Suchan M, Wagner S, Quaas A and Klussmann JP. LAG-3, TIM-3 and VISTA expression on tumor-infiltrating lymphocytes in oropharyngeal squamous cell carcinoma-potential biomarkers for targeted therapy concepts. Int J Mol Sci 2020; 22: 379.","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/jpm10040208","article-title":"Soluble immune checkpoints, gut metabolites and performance status as parameters of response to nivolumab treatment in NSCLC patients","volume":"10","author":"Zizzari","year":"2020","unstructured":"Zizzari IG, Di Filippo A, Scirocchi F, Di Pietro FR, Rahimi H, Ugolini A, Scagnoli S, Vernocchi P, Del Chierico F, Putignani L, Rughetti A, Marchetti P, Nuti M, Botticelli A and Napoletano C. Soluble immune checkpoints, gut metabolites and performance status as parameters of response to nivolumab treatment in NSCLC patients. J Pers Med 2020; 10: 208.","journal-title":"J Pers Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/ijmm.2021.4888","article-title":"Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review)","volume":"47","author":"Wang","year":"2021","unstructured":"Wang J, Xiang H, Lu Y and Wu T. Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review). Int J Mol Med 2021; 47: 55.","journal-title":"Int J Mol Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/cells13050397","article-title":"Neoadjuvant radiochemotherapy alters the immune and metabolic microenvironment in oral cancer-analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α expressions","volume":"13","author":"Weber","year":"2024","unstructured":"Weber M, Ries J, Braun K, Wehrhan F, Distel L, Geppert C, Lutz R, Kesting M and Trumet L. Neoadjuvant radiochemotherapy alters the immune and metabolic microenvironment in oral cancer-analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α expressions. Cells 2024; 13: 397.","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4103\/jcrt.jcrt_281_21","article-title":"Significance of vasohibin 1 in cancer patients: a systematic review and meta analysis","volume":"18","author":"Liu","year":"2022","unstructured":"Liu S, Han B, Sun M, Wang J, Sun Y and Wang Y. Significance of vasohibin 1 in cancer patients: a systematic review and meta analysis. J Cancer Res Ther 2022; 18: 567-575.","journal-title":"J Cancer Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12874-021-01273-2","article-title":"A strategy for optimal fitting of multiplicative and additive hazards regression models","volume":"21","author":"Lefebvre","year":"2021","unstructured":"Lefebvre F and Giorgi R. A strategy for optimal fitting of multiplicative and additive hazards regression models. BMC Med Res Methodol 2021; 21: 100.","journal-title":"BMC Med Res Methodol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jcms.2023.12.012","article-title":"Sentinel lymph node biopsy versus elective neck dissection in management of the clinically negative (cN0) neck in patients with oral squamous cell carcinoma: a systematic review and meta-analysis","volume":"52","author":"Al-Moraissi","year":"2024","unstructured":"Al-Moraissi EA, Marwan H, Elayah SA, Traxler-Weidenauer D, Paraskevopoulos K, Amir Rais M and Zimmermann M. Sentinel lymph node biopsy versus elective neck dissection in management of the clinically negative (cN0) neck in patients with oral squamous cell carcinoma: a systematic review and meta-analysis. J Craniomaxillofac Surg 2024; 52: 141-150.","journal-title":"J Craniomaxillofac Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcms.2025.04.016","article-title":"Distinctive lymph node metastasis characteristics and predictive model for young oral squamous cell carcinoma patients under 30","volume":"53","author":"YX","year":"2025","unstructured":"Wu YX, Cheng HY, Jia J, Chen GL and Yu ZL. Distinctive lymph node metastasis characteristics and predictive model for young oral squamous cell carcinoma patients under 30. J Craniomaxillofacial Surg 2025; 53: 1267-1274.","journal-title":"J Craniomaxillofacial Surg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ijom.2024.12.004","article-title":"Lymph node metastasis in level IIb neck dissection for clinically node-negative oral squamous cell carcinoma patients: an 11-year retrospective study","volume":"54","author":"Duvernay","year":"2025","unstructured":"Duvernay J, Garreau B, Dubreuil PA, Bondaz M, Majoufre C and Schlund M. Lymph node metastasis in level IIb neck dissection for clinically node-negative oral squamous cell carcinoma patients: an 11-year retrospective study. Int J Oral Maxillofac Surg 2025; 54: 577-580.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"155489","DOI":"10.1016\/j.prp.2024.155489","article-title":"Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances","volume":"261","author":"Jagadeesan","year":"2024","unstructured":"Jagadeesan D, Sathasivam KV, Fuloria NK, Balakrishnan V, Khor GH, Ravichandran M, Solyappan M, Fuloria S, Gupta G, Ahlawat A, Yadav G, Kaur P and Husseen B. Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances. Pathol Res Pract 2024; 261: 155489.","journal-title":"Pathol Res Pract"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Tehzeeb H, Hande A, Patil S, Sonone A, Pakhale A and Chavhan A. Correlation of clinical and pathological TNM staging with histopathological grading in oral squamous cell carcinoma. Cureus 2024; 16: e60912.","DOI":"10.7759\/cureus.60912"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1186\/s12903-024-04690-z","article-title":"Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery","volume":"24","author":"Dong","year":"2024","unstructured":"Dong L, Xue L, Cheng W, Tang J, Ran J and Li Y. Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery. BMC Oral Health 2024; 24: 919.","journal-title":"BMC Oral Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00784-024-05650-1","article-title":"Prevalence and implications of bilateral and solely contralateral lymph node metastases in oral squamous cell carcinoma","volume":"28","author":"Struckmeier","year":"2024","unstructured":"Struckmeier AK, Buchbender M, Agaimy A and Kesting M. Prevalence and implications of bilateral and solely contralateral lymph node metastases in oral squamous cell carcinoma. Clin Oral Investig 2024; 28: 267.","journal-title":"Clin Oral Investig"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Lin W, Huang M, Zhang Z, Chai T, Chen S, Gao L, Lin J and Kang M. A retrospective study of the relationship between the pathologic subtype and lymph node metastasis of lung adenocarcinomas of≤3 cm diameter. Medicine (Baltimore) 2020; 99: e21453.","DOI":"10.1097\/MD.0000000000021453"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2025.06.003","article-title":"Cytokine symphony: deciphering the tumor microenvironment and metastatic axis in oral cancer","volume":"85","author":"Manickasamy","year":"2025","unstructured":"Manickasamy MK, Vishwa R, BharathwajChetty B, Alqahtani MS, Abbas M and Kunnumakkara AB. Cytokine symphony: deciphering the tumor microenvironment and metastatic axis in oral cancer. Cytokine Growth Factor Rev 2025; 85: 1-10.","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1551048","DOI":"10.3389\/fnut.2025.1551048","article-title":"Clinical significance of preoperative nutrition and inflammation assessment tools in gastrointestinal cancer patients undergoing surgery: a retrospective cohort study","volume":"12","author":"Casalone","year":"2025","unstructured":"Casalone V, Bellomo SE, Berrino E, Bo S, Favaro E, Mellano A, Fenocchio E, Marchiò C and Sapino A. Clinical significance of preoperative nutrition and inflammation assessment tools in gastrointestinal cancer patients undergoing surgery: a retrospective cohort study. Front Nutr 2025; 12: 1551048.","journal-title":"Front Nutr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1323192","DOI":"10.3389\/fonc.2024.1323192","article-title":"Predictive value of serum albumin levels on cancer survival: a prospective cohort study","volume":"14","author":"Tang","year":"2024","unstructured":"Tang Q, Li X and Sun CR. Predictive value of serum albumin levels on cancer survival: a prospective cohort study. Frontiers in Oncology 2024; 14: 1323192.","journal-title":"Frontiers in Oncology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jfma.2020.12.013","article-title":"Serum levels and positive rates of tumor biomarkers in oral precancer patients","volume":"120","author":"YH","year":"2021","unstructured":"Wu YH, Lin PY, Yang JH, Kuo YS and Wu YC. Serum levels and positive rates of tumor biomarkers in oral precancer patients. J Formos Med Assoc 2021; 120: 1324-1331.","journal-title":"J Formos Med Assoc"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1186\/s12885-024-13010-1","article-title":"Serum cyfra21-1 is a new prognostic biomarker of penile squamous cell carcinoma","volume":"24","author":"Liang","year":"2024","unstructured":"Liang H, Zheng Q, Lu J, Li Z, Cai T, Han H, Zhou F, Qin Z, Yao K and Ye Y. Serum cyfra21-1 is a new prognostic biomarker of penile squamous cell carcinoma. BMC Cancer 2024; 24: 1240.","journal-title":"BMC Cancer"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-025-03293-y","article-title":"Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma","volume":"44","author":"Pourmir","year":"2025","unstructured":"Pourmir I, Benhamouda N, Tran T, Roux H, Pineau J, Gey A, Munoz A, Mabrouk N, Epaillard N, Verkarre V, Vano YA, Tartour E and Oudard S. Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma. J Exp Clin Cancer Res 2025; 44: 54.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"875152","DOI":"10.3389\/fimmu.2022.875152","article-title":"Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer","volume":"13","author":"Berg","year":"2022","unstructured":"Berg J, Halvorsen AR, Bengtson MB, Lindberg M, Halvorsen B, Aukrust P, Helland Å and Ueland T. Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer. Front Immunol 2022; 13: 875152.","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Peng Y, Zhang C, Rui Z, Tang W, Xu Y, Tao X, Zhao Q and Tong X. A comprehensive profiling of soluble immune checkpoints from the sera of patients with non-small cell lung cancer. J Clin Lab Anal 2022; 36: e24224.","DOI":"10.1002\/jcla.24224"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"887916","DOI":"10.3389\/fimmu.2022.887916","article-title":"Soluble immune checkpoint-related proteins in blood are associated with invasion and progression in non-small cell lung cancer","volume":"13","author":"Wang","year":"2022","unstructured":"Wang Q, He Y, Li W, Xu X, Hu Q, Bian Z, Xu A, Tu H, Wu M and Wu X. Soluble immune checkpoint-related proteins in blood are associated with invasion and progression in non-small cell lung cancer. Front Immunol 2022; 13: 887916.","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/16078454.2020.1738097","article-title":"Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients","volume":"25","author":"ZA","year":"2020","unstructured":"Yegin ZA, Can F, Aydın Kaynar L, Gökçen S, Eren Sadioğlu R, Özkurt ZN and Karacaoğlu Ö. Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients. Hematology 2020; 25: 125-133.","journal-title":"Hematology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/odi.15265","article-title":"Tumour-associated macrophages in oral squamous cell carcinoma","volume":"31","author":"Chaurasia","year":"2025","unstructured":"Chaurasia A, Brigi C, Daghrery A, Asa’ad F, Spirito F, Hasuike A, González-Alva P, Kojic DD, Ünsal RBK and Sivaramakrishnan G. Tumour-associated macrophages in oral squamous cell carcinoma. Oral Dis 2025; 31: 1546-1563.","journal-title":"Oral Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"115315","DOI":"10.1016\/j.celrep.2025.115315","article-title":"TGF-β1-mediated intercellular signaling fuels cooperative cellular invasion","volume":"44","author":"Khatib","year":"2025","unstructured":"Khatib TO, Pedro BA, Bombin S, Matsuk VY, Robinson IE, Webster SF, Marcus LJ, Summerbell ER, Tharp GK, Knippler CM, Bagchi P, Kowalski-Muegge J, Johnston HR, Ghalei H, Vertino PM, Mouw JK and Marcus AI. TGF-β1-mediated intercellular signaling fuels cooperative cellular invasion. Cell Reports 2025; 44: 115315.","journal-title":"Cell Reports"},{"key":"ref35","unstructured":"Sun CP, Bai Y, Jiang JQ and Wu JL. Effects of laparoscopic radical surgery in the treatment of colorectal cancer and correlations of VEGF and TGF-β1 with prognosis. Am J Transl Res 2021; 13: 12887-12896."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1038\/s41598-020-65145-3","article-title":"MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma","volume":"10","author":"Elahi","year":"2020","unstructured":"Elahi M and Rakhshan V. MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma. Sci Rep 2020; 10: 8475.","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Koyanagi T, Saga Y, Takahashi Y, Tamura K, Takahashi S, Taneichi A, Takei Y, Mizukami H and Fujiwara H. Forced vasohibin-1 expression increases paclitaxel sensitivity of ovarian cancer by inhibiting microtubule activity. Cancer Rep 2024; 7: e70100.","DOI":"10.1002\/cnr2.70100"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Kobayashi H, Kosaka T, Mikami S, Kimura T, Hongo H, Kosugi M, Sato Y and Oya M. Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan. BMJ Open 2021; 11: e056439.","DOI":"10.1136\/bmjopen-2021-056439"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1620\/tjem.243.107","article-title":"Vasohibin-1 is a poor prognostic factor of ovarian carcinoma","volume":"243","author":"Sano","year":"2017","unstructured":"Sano R, Kanomata N, Suzuki S, Shimoya K, Sato Y, Moriya T and Shiota M. Vasohibin-1 is a poor prognostic factor of ovarian carcinoma. Tohoku J Exp Med 2017; 243: 107-114.","journal-title":"Tohoku J Exp Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/cas.12911","article-title":"Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors","volume":"107","author":"Takahashi","year":"2016","unstructured":"Takahashi Y, Saga Y, Koyanagi T, Takei Y, Machida S, Taneichi A, Mizukami H, Sato Y, Matsubara S and Fujiwara H. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors. Cancer Sci 2016; 107: 629-637.","journal-title":"Cancer Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5551\/jat.43398","article-title":"Double-face of vasohibin-1 for the maintenance of vascular homeostasis and healthy longevity","volume":"25","author":"Sato","year":"2018","unstructured":"Sato Y. Double-face of vasohibin-1 for the maintenance of vascular homeostasis and healthy longevity. J Atheroscler Thromb 2018; 25: 461-466.","journal-title":"J Atheroscler Thromb"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Shen H, Zhang T and Wang S. A prediction model for lymph node metastasis of oral squamous cell carcinoma based on multiple risk factors. Clin Exp Dent Res 2024; 10: e70046.","DOI":"10.1002\/cre2.70046"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"660615","DOI":"10.3389\/fonc.2021.660615","article-title":"A combined prediction model for lymph node metastasis based on a molecular panel and clinicopathological factors in oral squamous cell carcinoma","volume":"11","author":"Wang","year":"2021","unstructured":"Wang S, Li T, Liu H, Wei W, Yang Y, Wang C, Li B, Han Z and Feng Z. A combined prediction model for lymph node metastasis based on a molecular panel and clinicopathological factors in oral squamous cell carcinoma. Front Oncol 2021; 11: 660615.","journal-title":"Front Oncol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40644-023-00552-z","article-title":"A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables","volume":"23","author":"Xu","year":"2023","unstructured":"Xu F, Peng L, Feng J, Zhu X, Pan Y, Hu Y, Gao X, Ma Y and He Y. A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables. Cancer Imaging 2023; 23: 34.","journal-title":"Cancer Imaging"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/11\/ajcr0168075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:24:52Z","timestamp":1768962292000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/11\/ajcr0168075.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/tmtw8336","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}